HEADER IMMUNE SYSTEM/INHIBITOR 04-MAR-10 3M1B TITLE CRYSTAL STRUCTURE OF HUMAN FCRN WITH A DIMERIC PEPTIDE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: IGG RECEPTOR FCRN LARGE SUBUNIT P51; COMPND 3 CHAIN: A, C, E, G; COMPND 4 FRAGMENT: UNP RESIDUES 24-290; COMPND 5 SYNONYM: FCRN, NEONATAL FC RECEPTOR, IGG FC FRAGMENT RECEPTOR COMPND 6 TRANSPORTER ALPHA CHAIN; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 10 CHAIN: B, D, F, H; COMPND 11 FRAGMENT: UNP RESIDUES 21-119; COMPND 12 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 13 ENGINEERED: YES; COMPND 14 MOL_ID: 3; COMPND 15 MOLECULE: DIMERIC PEPTIDE INHIBITOR; COMPND 16 CHAIN: I, J; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: FCGRT, FCRN; SOURCE 6 EXPRESSION_SYSTEM: CRICETINAE; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HAMSTERS; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 10026; SOURCE 9 EXPRESSION_SYSTEM_CELL: CHOK1SV CELLS; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 12 ORGANISM_COMMON: HUMAN; SOURCE 13 ORGANISM_TAXID: 9606; SOURCE 14 GENE: B2M, CDABP0092, HDCMA22P; SOURCE 15 EXPRESSION_SYSTEM: CRICETINAE; SOURCE 16 EXPRESSION_SYSTEM_COMMON: HAMSTERS; SOURCE 17 EXPRESSION_SYSTEM_TAXID: 10026; SOURCE 18 EXPRESSION_SYSTEM_CELL: CHOK1SV CELLS; SOURCE 19 MOL_ID: 3; SOURCE 20 SYNTHETIC: YES KEYWDS IMMUNOGLOBULIN BINDING PROTEIN, CELL MEMBRANE, DISULFIDE BOND, KEYWDS 2 GLYCOPROTEIN, IGG-BINDING PROTEIN, IMMUNOGLOBULIN DOMAIN, MEMBRANE, KEYWDS 3 RECEPTOR, TRANSMEMBRANE, AMYLOID, AMYLOIDOSIS, DISEASE MUTATION, KEYWDS 4 GLYCATION, IMMUNE RESPONSE, MHC I, PYRROLIDONE CARBOXYLIC ACID, KEYWDS 5 SECRETED, IMMUNE SYSTEM-IMMUNE SYSTEM INHIBITOR, IMMUNE SYSTEM- KEYWDS 6 INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.R.MEZO,V.SRIDHAR,J.BADGER,P.SAKORAFAS,V.NIENABER REVDAT 3 24-AUG-11 3M1B 1 HEADER LINK VERSN REVDAT 2 15-SEP-10 3M1B 1 JRNL REVDAT 1 16-JUN-10 3M1B 0 JRNL AUTH A.R.MEZO,V.SRIDHAR,J.BADGER,P.SAKORAFAS,V.NIENABER JRNL TITL X-RAY CRYSTAL STRUCTURES OF MONOMERIC AND DIMERIC PEPTIDE JRNL TITL 2 INHIBITORS IN COMPLEX WITH THE HUMAN NEONATAL FC RECEPTOR, JRNL TITL 3 FCRN. JRNL REF J.BIOL.CHEM. V. 285 27694 2010 JRNL REFN ISSN 0021-9258 JRNL PMID 20592032 JRNL DOI 10.1074/JBC.M110.120667 REMARK 2 REMARK 2 RESOLUTION. 3.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 3.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 37.24 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 27550 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.318 REMARK 3 R VALUE (WORKING SET) : 0.314 REMARK 3 FREE R VALUE : 0.397 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1475 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 11241 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 106.58 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.44000 REMARK 3 B22 (A**2) : 1.06000 REMARK 3 B33 (A**2) : 0.38000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -0.04000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.793 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.901 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 50.517 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : NULL ; NULL REMARK 3 ANGLE DISTANCE (A) : NULL ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : NULL ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3M1B COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 15-MAR-10. REMARK 100 THE RCSB ID CODE IS RCSB057982. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : NULL REMARK 200 PH : 4.2 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.0 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 29051 REMARK 200 RESOLUTION RANGE HIGH (A) : 3.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -4.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 90.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 3.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 3.20 REMARK 200 COMPLETENESS FOR SHELL (%) : 58.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3M17 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.31 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.63 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 2UL PROTEIN:PEPTIDE WITH 2UL BUFFER REMARK 280 CONTAINING 100 MM PHOSPHATE/CITRIC ACID, 22% PEG 1000 AND 8% REMARK 280 ETHANOL , PH 4.2, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 79.21550 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 4 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 5 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 6 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 7 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 8 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 9 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: I REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 10 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: J REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ALA A 1 REMARK 465 GLU A 2 REMARK 465 SER A 3 REMARK 465 HIS A 4 REMARK 465 ALA C 1 REMARK 465 GLU C 2 REMARK 465 SER C 3 REMARK 465 HIS C 4 REMARK 465 ALA E 1 REMARK 465 GLU E 2 REMARK 465 SER E 3 REMARK 465 HIS E 4 REMARK 465 ALA G 1 REMARK 465 GLU G 2 REMARK 465 SER G 3 REMARK 465 HIS G 4 REMARK 465 ACE I 0 REMARK 465 ARG I 1 REMARK 465 PHE I 2 REMARK 465 LYS I 14 REMARK 465 NH2 I 15 REMARK 465 ACE J 100 REMARK 465 ARG J 101 REMARK 465 LYS J 114 REMARK 465 NH2 J 115 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LEU A 5 CG CD1 CD2 REMARK 470 GLU A 46 CG CD OE1 OE2 REMARK 470 VAL A 57 CG1 CG2 REMARK 470 SER A 58 OG REMARK 470 LYS A 63 CD CE NZ REMARK 470 LYS A 73 CD CE NZ REMARK 470 LYS A 85 CG CD CE NZ REMARK 470 ASN A 102 CG OD1 ND2 REMARK 470 LYS A 123 CG CD CE NZ REMARK 470 GLN A 143 CG CD OE1 NE2 REMARK 470 LYS A 146 CD CE NZ REMARK 470 LEU A 152 CG CD1 CD2 REMARK 470 PHE A 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG A 164 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 177 CE NZ REMARK 470 LYS A 185 CG CD CE NZ REMARK 470 ARG A 187 CG CD NE CZ NH1 NH2 REMARK 470 SER A 189 OG REMARK 470 SER A 190 OG REMARK 470 PHE A 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER A 194 OG REMARK 470 GLN A 209 CD OE1 NE2 REMARK 470 ARG A 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 215 CG OD1 ND2 REMARK 470 LEU A 217 CG CD1 CD2 REMARK 470 GLN A 223 CG CD OE1 NE2 REMARK 470 LYS A 243 CG CD CE NZ REMARK 470 HIS A 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN A 255 CG CD OE1 NE2 REMARK 470 LEU A 267 CG CD1 CD2 REMARK 470 LYS B 48 CG CD CE NZ REMARK 470 LYS B 58 CD CE NZ REMARK 470 LYS B 75 CG CD CE NZ REMARK 470 GLU B 77 CG CD OE1 OE2 REMARK 470 LYS B 91 CD CE NZ REMARK 470 LYS B 94 CD CE NZ REMARK 470 LEU C 5 CG CD1 CD2 REMARK 470 GLU C 46 CG CD OE1 OE2 REMARK 470 VAL C 57 CG1 CG2 REMARK 470 SER C 58 OG REMARK 470 LYS C 63 CD CE NZ REMARK 470 LYS C 73 CD CE NZ REMARK 470 LYS C 85 CG CD CE NZ REMARK 470 ASN C 102 CG OD1 ND2 REMARK 470 LYS C 123 CG CD CE NZ REMARK 470 GLN C 143 CG CD OE1 NE2 REMARK 470 LYS C 146 CD CE NZ REMARK 470 LEU C 152 CG CD1 CD2 REMARK 470 PHE C 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG C 164 CG CD NE CZ NH1 NH2 REMARK 470 LYS C 177 CE NZ REMARK 470 LYS C 185 CG CD CE NZ REMARK 470 ARG C 187 CG CD NE CZ NH1 NH2 REMARK 470 SER C 189 OG REMARK 470 SER C 190 OG REMARK 470 PHE C 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER C 194 OG REMARK 470 GLN C 209 CD OE1 NE2 REMARK 470 ARG C 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG C 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN C 215 CG OD1 ND2 REMARK 470 LEU C 217 CG CD1 CD2 REMARK 470 GLN C 223 CG CD OE1 NE2 REMARK 470 LYS C 243 CG CD CE NZ REMARK 470 HIS C 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN C 255 CG CD OE1 NE2 REMARK 470 LEU C 267 CG CD1 CD2 REMARK 470 LYS D 48 CG CD CE NZ REMARK 470 LYS D 58 CD CE NZ REMARK 470 LYS D 75 CG CD CE NZ REMARK 470 GLU D 77 CG CD OE1 OE2 REMARK 470 LYS D 91 CD CE NZ REMARK 470 LYS D 94 CD CE NZ REMARK 470 LEU E 5 CG CD1 CD2 REMARK 470 GLU E 46 CG CD OE1 OE2 REMARK 470 VAL E 57 CG1 CG2 REMARK 470 SER E 58 OG REMARK 470 LYS E 63 CD CE NZ REMARK 470 LYS E 73 CD CE NZ REMARK 470 LYS E 85 CG CD CE NZ REMARK 470 ASN E 102 CG OD1 ND2 REMARK 470 LYS E 123 CG CD CE NZ REMARK 470 GLN E 143 CG CD OE1 NE2 REMARK 470 LYS E 146 CD CE NZ REMARK 470 LEU E 152 CG CD1 CD2 REMARK 470 PHE E 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG E 164 CG CD NE CZ NH1 NH2 REMARK 470 LYS E 177 CE NZ REMARK 470 LYS E 185 CG CD CE NZ REMARK 470 ARG E 187 CG CD NE CZ NH1 NH2 REMARK 470 SER E 189 OG REMARK 470 SER E 190 OG REMARK 470 PHE E 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER E 194 OG REMARK 470 GLN E 209 CD OE1 NE2 REMARK 470 ARG E 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG E 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN E 215 CG OD1 ND2 REMARK 470 LEU E 217 CG CD1 CD2 REMARK 470 GLN E 223 CG CD OE1 NE2 REMARK 470 LYS E 243 CG CD CE NZ REMARK 470 HIS E 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN E 255 CG CD OE1 NE2 REMARK 470 LEU E 267 CG CD1 CD2 REMARK 470 LYS F 48 CG CD CE NZ REMARK 470 LYS F 58 CD CE NZ REMARK 470 LYS F 75 CG CD CE NZ REMARK 470 GLU F 77 CG CD OE1 OE2 REMARK 470 LYS F 91 CD CE NZ REMARK 470 LYS F 94 CD CE NZ REMARK 470 LEU G 5 CG CD1 CD2 REMARK 470 GLU G 46 CG CD OE1 OE2 REMARK 470 VAL G 57 CG1 CG2 REMARK 470 SER G 58 OG REMARK 470 LYS G 63 CD CE NZ REMARK 470 LYS G 73 CD CE NZ REMARK 470 LYS G 85 CG CD CE NZ REMARK 470 ASN G 102 CG OD1 ND2 REMARK 470 LYS G 123 CG CD CE NZ REMARK 470 GLN G 143 CG CD OE1 NE2 REMARK 470 LYS G 146 CD CE NZ REMARK 470 LEU G 152 CG CD1 CD2 REMARK 470 PHE G 157 CG CD1 CD2 CE1 CE2 CZ REMARK 470 ARG G 164 CG CD NE CZ NH1 NH2 REMARK 470 LYS G 177 CE NZ REMARK 470 LYS G 185 CG CD CE NZ REMARK 470 ARG G 187 CG CD NE CZ NH1 NH2 REMARK 470 SER G 189 OG REMARK 470 SER G 190 OG REMARK 470 PHE G 193 CG CD1 CD2 CE1 CE2 CZ REMARK 470 SER G 194 OG REMARK 470 GLN G 209 CD OE1 NE2 REMARK 470 ARG G 211 CG CD NE CZ NH1 NH2 REMARK 470 ARG G 214 CG CD NE CZ NH1 NH2 REMARK 470 ASN G 215 CG OD1 ND2 REMARK 470 LEU G 217 CG CD1 CD2 REMARK 470 GLN G 223 CG CD OE1 NE2 REMARK 470 LYS G 243 CG CD CE NZ REMARK 470 HIS G 249 CG ND1 CD2 CE1 NE2 REMARK 470 GLN G 255 CG CD OE1 NE2 REMARK 470 LEU G 267 CG CD1 CD2 REMARK 470 LYS H 48 CG CD CE NZ REMARK 470 LYS H 58 CD CE NZ REMARK 470 LYS H 75 CG CD CE NZ REMARK 470 GLU H 77 CG CD OE1 OE2 REMARK 470 LYS H 91 CD CE NZ REMARK 470 LYS H 94 CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O PHE J 102 N LE1 J 103 1.39 REMARK 500 ND2 ASN H 17 OE1 GLU H 74 2.05 REMARK 500 OD2 ASP A 67 NH2 ARG A 162 2.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO H 5 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PRO A 19 102.06 -57.06 REMARK 500 TYR A 35 -5.76 -152.86 REMARK 500 TYR A 38 132.56 177.41 REMARK 500 ALA A 50 1.00 -62.20 REMARK 500 ASN A 55 84.83 -53.93 REMARK 500 SER A 58 -92.36 54.02 REMARK 500 PRO A 100 -71.46 -86.65 REMARK 500 ASN A 102 -14.88 64.25 REMARK 500 PHE A 117 -5.81 -146.60 REMARK 500 ALA A 134 25.41 -74.30 REMARK 500 LYS A 146 6.94 56.92 REMARK 500 LYS A 150 29.38 -76.00 REMARK 500 GLU A 151 -65.31 -123.97 REMARK 500 CYS A 159 -73.64 -61.27 REMARK 500 GLU A 165 -78.72 -90.50 REMARK 500 HIS A 166 -33.65 -39.39 REMARK 500 SER A 189 -157.61 -108.80 REMARK 500 PRO A 191 96.21 -43.99 REMARK 500 PHE A 193 154.98 171.01 REMARK 500 PRO A 205 -179.02 -65.93 REMARK 500 GLU A 207 85.71 -55.50 REMARK 500 ASN A 215 58.78 22.34 REMARK 500 ALA A 219 -48.90 -156.39 REMARK 500 ASN A 229 -165.79 -102.11 REMARK 500 HIS A 249 50.35 -90.53 REMARK 500 ASN B 21 -144.11 -153.79 REMARK 500 PRO B 32 -133.37 -71.06 REMARK 500 ASN B 42 77.01 58.10 REMARK 500 ASP B 59 10.03 -64.22 REMARK 500 TRP B 60 -21.73 77.85 REMARK 500 TYR C 38 124.91 177.01 REMARK 500 VAL C 57 56.59 -69.94 REMARK 500 SER C 58 -52.13 45.74 REMARK 500 THR C 65 -79.30 -52.73 REMARK 500 GLU C 97 125.59 -173.26 REMARK 500 ASP C 101 32.90 -144.16 REMARK 500 ASN C 102 -6.52 75.57 REMARK 500 ASN C 113 59.15 21.61 REMARK 500 PHE C 117 -28.62 -152.62 REMARK 500 ASP C 130 -36.92 -140.74 REMARK 500 LYS C 150 -7.21 -56.90 REMARK 500 PHE C 157 -87.32 -98.02 REMARK 500 CYS C 159 -70.57 -61.77 REMARK 500 LEU C 167 1.87 -65.36 REMARK 500 GLU C 168 -73.19 -118.27 REMARK 500 GLU C 175 6.22 -63.73 REMARK 500 LEU C 184 39.18 -155.71 REMARK 500 SER C 189 -136.86 -86.08 REMARK 500 CYS C 198 78.18 -107.87 REMARK 500 SER C 202 109.44 55.56 REMARK 500 REMARK 500 THIS ENTRY HAS 132 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 LE1 I 3 THR I 4 -124.83 REMARK 500 GLY I 8 SAR I 9 -145.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 LE1 I 3 19.28 REMARK 500 PHE J 102 -65.75 REMARK 500 LE1 J 103 33.93 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3M17 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF HUMAN FCRN WITH A MONOMERIC PEPTIDE REMARK 900 INHIBITOR REMARK 999 REMARK 999 SEQUENCE REMARK 999 ACE AT THE N-TERMINUS OF CHAIN I IS COVALENTLY BONDED WITH ACE AT REMARK 999 THE N-TERMINUS OF CHAIN J DBREF 3M1B A 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M1B B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M1B C 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M1B D 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M1B E 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M1B F 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M1B G 1 267 UNP P55899 FCGRN_HUMAN 24 290 DBREF 3M1B H 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3M1B I 2 14 PDB 3M1B 3M1B 2 14 DBREF 3M1B J 102 114 PDB 3M1B 3M1B 102 114 SEQRES 1 A 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 A 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 A 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 A 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 A 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 A 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 A 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 A 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 A 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 A 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 A 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 A 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 A 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 A 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 A 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 A 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 A 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 A 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 A 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 A 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 A 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 B 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 B 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 B 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 B 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 B 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 B 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 B 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 B 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 C 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 C 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 C 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 C 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 C 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 C 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 C 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 C 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 C 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 C 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 C 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 C 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 C 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 C 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 C 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 C 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 C 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 C 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 C 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 C 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 D 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 D 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 D 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 D 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 D 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 D 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 D 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 D 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 E 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 E 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 E 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 E 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 E 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 E 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 E 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 E 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 E 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 E 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 E 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 E 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 E 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 E 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 E 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 E 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 E 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 E 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 E 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 E 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 E 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 F 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 F 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 F 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 F 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 F 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 F 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 F 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 F 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 G 267 ALA GLU SER HIS LEU SER LEU LEU TYR HIS LEU THR ALA SEQRES 2 G 267 VAL SER SER PRO ALA PRO GLY THR PRO ALA PHE TRP VAL SEQRES 3 G 267 SER GLY TRP LEU GLY PRO GLN GLN TYR LEU SER TYR ASN SEQRES 4 G 267 SER LEU ARG GLY GLU ALA GLU PRO CYS GLY ALA TRP VAL SEQRES 5 G 267 TRP GLU ASN GLN VAL SER TRP TYR TRP GLU LYS GLU THR SEQRES 6 G 267 THR ASP LEU ARG ILE LYS GLU LYS LEU PHE LEU GLU ALA SEQRES 7 G 267 PHE LYS ALA LEU GLY GLY LYS GLY PRO TYR THR LEU GLN SEQRES 8 G 267 GLY LEU LEU GLY CYS GLU LEU GLY PRO ASP ASN THR SER SEQRES 9 G 267 VAL PRO THR ALA LYS PHE ALA LEU ASN GLY GLU GLU PHE SEQRES 10 G 267 MET ASN PHE ASP LEU LYS GLN GLY THR TRP GLY GLY ASP SEQRES 11 G 267 TRP PRO GLU ALA LEU ALA ILE SER GLN ARG TRP GLN GLN SEQRES 12 G 267 GLN ASP LYS ALA ALA ASN LYS GLU LEU THR PHE LEU LEU SEQRES 13 G 267 PHE SER CYS PRO HIS ARG LEU ARG GLU HIS LEU GLU ARG SEQRES 14 G 267 GLY ARG GLY ASN LEU GLU TRP LYS GLU PRO PRO SER MET SEQRES 15 G 267 ARG LEU LYS ALA ARG PRO SER SER PRO GLY PHE SER VAL SEQRES 16 G 267 LEU THR CYS SER ALA PHE SER PHE TYR PRO PRO GLU LEU SEQRES 17 G 267 GLN LEU ARG PHE LEU ARG ASN GLY LEU ALA ALA GLY THR SEQRES 18 G 267 GLY GLN GLY ASP PHE GLY PRO ASN SER ASP GLY SER PHE SEQRES 19 G 267 HIS ALA SER SER SER LEU THR VAL LYS SER GLY ASP GLU SEQRES 20 G 267 HIS HIS TYR CYS CYS ILE VAL GLN HIS ALA GLY LEU ALA SEQRES 21 G 267 GLN PRO LEU ARG VAL GLU LEU SEQRES 1 H 99 ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG HIS SEQRES 2 H 99 PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS TYR SEQRES 3 H 99 VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP LEU SEQRES 4 H 99 LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SER SEQRES 5 H 99 ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU LEU SEQRES 6 H 99 TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU TYR SEQRES 7 H 99 ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO LYS SEQRES 8 H 99 ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 I 16 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 I 16 CYS LYS NH2 SEQRES 1 J 16 ACE ARG PHE LE1 THR GLY HIS PHE GLY SAR MLE TYR PRO SEQRES 2 J 16 CYS LYS NH2 MODRES 3M1B LE1 I 3 VAL 3-SULFANYL-L-VALINE MODRES 3M1B SAR I 9 GLY SARCOSINE MODRES 3M1B MLE I 10 LEU N-METHYLLEUCINE MODRES 3M1B LE1 J 103 VAL 3-SULFANYL-L-VALINE MODRES 3M1B SAR J 109 GLY SARCOSINE MODRES 3M1B MLE J 110 LEU N-METHYLLEUCINE HET LE1 I 3 8 HET SAR I 9 5 HET MLE I 10 9 HET LE1 J 103 8 HET SAR J 109 5 HET MLE J 110 9 HETNAM LE1 3-SULFANYL-L-VALINE HETNAM SAR SARCOSINE HETNAM MLE N-METHYLLEUCINE HETSYN LE1 L-LE1ICILLAMINE FORMUL 9 LE1 2(C5 H11 N O2 S) FORMUL 9 SAR 2(C3 H7 N O2) FORMUL 9 MLE 2(C7 H15 N O2) HELIX 1 1 GLY A 49 VAL A 52 5 4 HELIX 2 2 TRP A 59 LEU A 82 1 24 HELIX 3 3 PRO A 132 LEU A 135 5 4 HELIX 4 4 ALA A 136 GLN A 144 1 9 HELIX 5 5 ALA A 148 PHE A 157 1 10 HELIX 6 6 PHE A 157 TRP A 176 1 20 HELIX 7 7 GLY A 245 HIS A 248 5 4 HELIX 8 8 CYS C 48 TRP C 53 5 6 HELIX 9 9 TRP C 59 ALA C 81 1 23 HELIX 10 10 TRP C 131 GLN C 139 1 9 HELIX 11 11 ALA C 148 PHE C 157 1 10 HELIX 12 12 PHE C 157 GLY C 170 1 14 HELIX 13 13 GLY C 170 GLU C 175 1 6 HELIX 14 14 ASP C 246 TYR C 250 5 5 HELIX 15 15 CYS E 48 VAL E 52 5 5 HELIX 16 16 TRP E 59 PHE E 79 1 21 HELIX 17 17 LEU E 122 GLY E 125 5 4 HELIX 18 18 TRP E 131 GLN E 144 1 14 HELIX 19 19 ALA E 148 PHE E 157 1 10 HELIX 20 20 SER E 158 GLY E 170 1 13 HELIX 21 21 GLY E 170 TRP E 176 1 7 HELIX 22 22 ASP E 246 HIS E 248 5 3 HELIX 23 23 TRP G 59 ALA G 81 1 23 HELIX 24 24 ASP G 121 GLY G 125 5 5 HELIX 25 25 PRO G 132 GLN G 144 1 13 HELIX 26 26 LYS G 146 PHE G 157 1 12 HELIX 27 27 PHE G 157 ARG G 169 1 13 HELIX 28 28 GLY G 170 TRP G 176 1 7 SHEET 1 A 6 GLU A 46 PRO A 47 0 SHEET 2 A 6 GLN A 33 TYR A 38 -1 N SER A 37 O GLU A 46 SHEET 3 A 6 PHE A 24 LEU A 30 -1 N LEU A 30 O GLN A 33 SHEET 4 A 6 LEU A 7 VAL A 14 -1 N LEU A 8 O TRP A 29 SHEET 5 A 6 THR A 89 LEU A 98 -1 O LEU A 94 N TYR A 9 SHEET 6 A 6 SER A 104 PRO A 106 -1 O VAL A 105 N GLU A 97 SHEET 1 B 8 GLU A 46 PRO A 47 0 SHEET 2 B 8 GLN A 33 TYR A 38 -1 N SER A 37 O GLU A 46 SHEET 3 B 8 PHE A 24 LEU A 30 -1 N LEU A 30 O GLN A 33 SHEET 4 B 8 LEU A 7 VAL A 14 -1 N LEU A 8 O TRP A 29 SHEET 5 B 8 THR A 89 LEU A 98 -1 O LEU A 94 N TYR A 9 SHEET 6 B 8 LYS A 109 LEU A 112 -1 O LYS A 109 N LEU A 93 SHEET 7 B 8 GLU A 116 ASP A 121 -1 O PHE A 117 N PHE A 110 SHEET 8 B 8 THR A 126 GLY A 128 -1 O GLY A 128 N ASN A 119 SHEET 1 C 4 SER A 181 LYS A 185 0 SHEET 2 C 4 THR A 197 PHE A 203 -1 O PHE A 201 N SER A 181 SHEET 3 C 4 PHE A 234 SER A 239 -1 O SER A 238 N CYS A 198 SHEET 4 C 4 GLN A 223 PRO A 228 -1 N GLN A 223 O SER A 239 SHEET 1 D 2 SER A 194 VAL A 195 0 SHEET 2 D 2 THR A 241 VAL A 242 -1 O VAL A 242 N SER A 194 SHEET 1 E 4 LEU A 217 ALA A 218 0 SHEET 2 E 4 GLN A 209 ARG A 214 -1 N ARG A 214 O LEU A 217 SHEET 3 E 4 TYR A 250 GLN A 255 -1 O CYS A 251 N LEU A 213 SHEET 4 E 4 LEU A 263 VAL A 265 -1 O VAL A 265 N CYS A 252 SHEET 1 F 4 VAL B 9 TYR B 10 0 SHEET 2 F 4 LEU B 23 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 F 4 PHE B 62 THR B 68 -1 O PHE B 62 N GLY B 29 SHEET 4 F 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 G 4 VAL B 9 TYR B 10 0 SHEET 2 G 4 LEU B 23 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 G 4 PHE B 62 THR B 68 -1 O PHE B 62 N GLY B 29 SHEET 4 G 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 H 4 GLU B 44 ARG B 45 0 SHEET 2 H 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 H 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 H 4 LYS B 91 LYS B 94 -1 O LYS B 91 N VAL B 82 SHEET 1 I 7 GLN C 33 ASN C 39 0 SHEET 2 I 7 PHE C 24 LEU C 30 -1 N GLY C 28 O TYR C 35 SHEET 3 I 7 LEU C 7 VAL C 14 -1 N THR C 12 O TRP C 25 SHEET 4 I 7 THR C 89 CYS C 96 -1 O LEU C 94 N TYR C 9 SHEET 5 I 7 PHE C 110 LEU C 112 -1 O ALA C 111 N GLN C 91 SHEET 6 I 7 GLU C 115 ASP C 121 -1 O MET C 118 N PHE C 110 SHEET 7 I 7 THR C 126 GLY C 128 -1 O THR C 126 N ASP C 121 SHEET 1 J 4 SER C 181 MET C 182 0 SHEET 2 J 4 ALA C 200 PHE C 203 -1 O PHE C 201 N SER C 181 SHEET 3 J 4 PHE C 234 ALA C 236 -1 O PHE C 234 N PHE C 203 SHEET 4 J 4 PHE C 226 PRO C 228 -1 N GLY C 227 O HIS C 235 SHEET 1 K 2 PHE C 193 SER C 194 0 SHEET 2 K 2 VAL C 242 LYS C 243 -1 O VAL C 242 N SER C 194 SHEET 1 L 3 LEU C 208 PHE C 212 0 SHEET 2 L 3 CYS C 252 HIS C 256 -1 O ILE C 253 N ARG C 211 SHEET 3 L 3 LEU C 263 VAL C 265 -1 O VAL C 265 N CYS C 252 SHEET 1 M 4 LYS D 6 SER D 11 0 SHEET 2 M 4 ASN D 21 PHE D 30 -1 O ASN D 24 N TYR D 10 SHEET 3 M 4 PHE D 62 PHE D 70 -1 O TYR D 66 N CYS D 25 SHEET 4 M 4 GLU D 50 SER D 55 -1 N SER D 52 O LEU D 65 SHEET 1 N 3 ILE D 35 LYS D 41 0 SHEET 2 N 3 TYR D 78 HIS D 84 -1 O ALA D 79 N LEU D 40 SHEET 3 N 3 LYS D 91 LYS D 94 -1 O VAL D 93 N CYS D 80 SHEET 1 O 7 GLN E 33 ASN E 39 0 SHEET 2 O 7 PHE E 24 LEU E 30 -1 N GLY E 28 O TYR E 35 SHEET 3 O 7 SER E 6 VAL E 14 -1 N LEU E 8 O TRP E 29 SHEET 4 O 7 THR E 89 GLU E 97 -1 O LEU E 90 N ALA E 13 SHEET 5 O 7 THR E 107 LEU E 112 -1 O LYS E 109 N LEU E 93 SHEET 6 O 7 GLU E 115 ASP E 121 -1 O PHE E 117 N PHE E 110 SHEET 7 O 7 THR E 126 GLY E 128 -1 O THR E 126 N ASP E 121 SHEET 1 P 4 SER E 181 PRO E 188 0 SHEET 2 P 4 SER E 194 PHE E 201 -1 O SER E 199 N ARG E 183 SHEET 3 P 4 PHE E 234 VAL E 242 -1 O ALA E 236 N ALA E 200 SHEET 4 P 4 GLN E 223 GLY E 224 -1 N GLN E 223 O SER E 239 SHEET 1 Q 4 SER E 181 PRO E 188 0 SHEET 2 Q 4 SER E 194 PHE E 201 -1 O SER E 199 N ARG E 183 SHEET 3 Q 4 PHE E 234 VAL E 242 -1 O ALA E 236 N ALA E 200 SHEET 4 Q 4 GLY E 227 PRO E 228 -1 N GLY E 227 O HIS E 235 SHEET 1 R 4 GLN E 209 LEU E 210 0 SHEET 2 R 4 TYR E 250 GLN E 255 -1 O GLN E 255 N GLN E 209 SHEET 3 R 4 LEU E 213 ARG E 214 -1 N LEU E 213 O CYS E 251 SHEET 4 R 4 LEU E 217 ALA E 218 -1 O LEU E 217 N ARG E 214 SHEET 1 S 3 GLN E 209 LEU E 210 0 SHEET 2 S 3 TYR E 250 GLN E 255 -1 O GLN E 255 N GLN E 209 SHEET 3 S 3 LEU E 263 VAL E 265 -1 O VAL E 265 N CYS E 252 SHEET 1 T 4 VAL F 9 SER F 11 0 SHEET 2 T 4 ASN F 21 SER F 28 -1 O ASN F 24 N TYR F 10 SHEET 3 T 4 PHE F 62 PHE F 70 -1 O PHE F 70 N ASN F 21 SHEET 4 T 4 GLU F 50 HIS F 51 -1 N GLU F 50 O TYR F 67 SHEET 1 U 4 VAL F 9 SER F 11 0 SHEET 2 U 4 ASN F 21 SER F 28 -1 O ASN F 24 N TYR F 10 SHEET 3 U 4 PHE F 62 PHE F 70 -1 O PHE F 70 N ASN F 21 SHEET 4 U 4 SER F 55 PHE F 56 -1 N SER F 55 O TYR F 63 SHEET 1 V 2 GLU F 36 LYS F 41 0 SHEET 2 V 2 TYR F 78 ASN F 83 -1 O ARG F 81 N ASP F 38 SHEET 1 W 5 GLN G 33 ASN G 39 0 SHEET 2 W 5 PHE G 24 LEU G 30 -1 N GLY G 28 O LEU G 36 SHEET 3 W 5 LEU G 7 ALA G 13 -1 N LEU G 8 O TRP G 29 SHEET 4 W 5 LEU G 90 GLU G 97 -1 O GLY G 92 N LEU G 11 SHEET 5 W 5 VAL G 105 PRO G 106 -1 O VAL G 105 N GLU G 97 SHEET 1 X 6 GLN G 33 ASN G 39 0 SHEET 2 X 6 PHE G 24 LEU G 30 -1 N GLY G 28 O LEU G 36 SHEET 3 X 6 LEU G 7 ALA G 13 -1 N LEU G 8 O TRP G 29 SHEET 4 X 6 LEU G 90 GLU G 97 -1 O GLY G 92 N LEU G 11 SHEET 5 X 6 PHE G 110 LEU G 112 -1 O ALA G 111 N GLN G 91 SHEET 6 X 6 GLU G 115 MET G 118 -1 O PHE G 117 N PHE G 110 SHEET 1 Y 4 SER G 181 PRO G 188 0 SHEET 2 Y 4 PHE G 193 PHE G 203 -1 O PHE G 201 N SER G 181 SHEET 3 Y 4 PHE G 234 LYS G 243 -1 O PHE G 234 N PHE G 203 SHEET 4 Y 4 GLN G 223 PRO G 228 -1 N GLN G 223 O SER G 239 SHEET 1 Z 3 LEU G 208 ARG G 211 0 SHEET 2 Z 3 CYS G 252 HIS G 256 -1 O ILE G 253 N ARG G 211 SHEET 3 Z 3 LEU G 263 VAL G 265 -1 O VAL G 265 N CYS G 252 SHEET 1 AA 2 LEU G 213 ARG G 214 0 SHEET 2 AA 2 LEU G 217 ALA G 218 -1 O LEU G 217 N ARG G 214 SHEET 1 AB 4 LYS H 6 SER H 11 0 SHEET 2 AB 4 ASN H 21 PHE H 30 -1 O TYR H 26 N GLN H 8 SHEET 3 AB 4 PHE H 62 PHE H 70 -1 O PHE H 70 N ASN H 21 SHEET 4 AB 4 GLU H 50 PHE H 56 -1 N GLU H 50 O TYR H 67 SHEET 1 AC 4 GLU H 44 ARG H 45 0 SHEET 2 AC 4 ILE H 35 LYS H 41 -1 N LYS H 41 O GLU H 44 SHEET 3 AC 4 TYR H 78 HIS H 84 -1 O ASN H 83 N GLU H 36 SHEET 4 AC 4 LYS H 91 LYS H 94 -1 O LYS H 91 N VAL H 82 SHEET 1 AD 2 LE1 J 103 THR J 104 0 SHEET 2 AD 2 MLE J 110 TYR J 111 -1 O TYR J 111 N LE1 J 103 SSBOND 1 CYS A 96 CYS A 159 1555 1555 2.06 SSBOND 2 CYS A 198 CYS A 252 1555 1555 2.06 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.04 SSBOND 4 CYS C 96 CYS C 159 1555 1555 2.04 SSBOND 5 CYS C 198 CYS C 252 1555 1555 2.04 SSBOND 6 CYS D 25 CYS D 80 1555 1555 2.04 SSBOND 7 CYS E 96 CYS E 159 1555 1555 2.06 SSBOND 8 CYS E 198 CYS E 252 1555 1555 2.05 SSBOND 9 CYS F 25 CYS F 80 1555 1555 2.03 SSBOND 10 CYS G 96 CYS G 159 1555 1555 2.04 SSBOND 11 CYS G 198 CYS G 252 1555 1555 2.05 SSBOND 12 CYS H 25 CYS H 80 1555 1555 2.05 SSBOND 13 LE1 I 3 CYS I 13 1555 1555 2.05 SSBOND 14 LE1 J 103 CYS J 113 1555 1555 2.04 LINK C LE1 I 3 N THR I 4 1555 1555 1.34 LINK C GLY I 8 N SAR I 9 1555 1555 1.33 LINK C SAR I 9 N MLE I 10 1555 1555 1.33 LINK C MLE I 10 N TYR I 11 1555 1555 1.33 LINK C PHE J 102 N LE1 J 103 1555 1555 1.34 LINK C LE1 J 103 N THR J 104 1555 1555 1.33 LINK C GLY J 108 N SAR J 109 1555 1555 1.34 LINK C SAR J 109 N MLE J 110 1555 1555 1.33 LINK C MLE J 110 N TYR J 111 1555 1555 1.33 CISPEP 1 GLY A 86 PRO A 87 0 -14.18 CISPEP 2 TYR A 204 PRO A 205 0 -0.37 CISPEP 3 HIS B 31 PRO B 32 0 2.96 CISPEP 4 GLY C 86 PRO C 87 0 -1.95 CISPEP 5 TYR C 204 PRO C 205 0 -4.13 CISPEP 6 HIS D 31 PRO D 32 0 5.19 CISPEP 7 GLY E 86 PRO E 87 0 -1.75 CISPEP 8 TYR E 204 PRO E 205 0 -1.70 CISPEP 9 HIS F 31 PRO F 32 0 -2.96 CISPEP 10 GLY G 86 PRO G 87 0 -5.56 CISPEP 11 TYR G 204 PRO G 205 0 -6.50 CISPEP 12 HIS H 31 PRO H 32 0 -1.97 CRYST1 68.050 158.431 82.539 90.00 90.11 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.014695 0.000000 0.000029 0.00000 SCALE2 0.000000 0.006312 0.000000 0.00000 SCALE3 0.000000 0.000000 0.012116 0.00000 MASTER 567 0 6 28 121 0 0 6 0 0 0 120 END